Literature DB >> 30326154

Ancillary factors in the treatment of orofacial pain: A topical narrative review.

Marcello Melis1,2, Massimiliano Di Giosia3, Luana Colloca4.   

Abstract

Ancillary factors, not directly related to treatment, often play a significant role by affecting therapeutic outcome. A search of the literature was conducted including words related to the placebo phenomenon and orofacial diseases. Therefore, critical factors have been grouped into three major categories: (a) the natural course of the diseases; (b) the regression of the symptoms to their mean intensity; and (c) placebo response. This topical narrative review describes the elements mentioned above, provides an up-to-date overview of the hot topics and gaps in the field and indicates developing and future research direction of the orofacial pain field. Such a knowledge might be positively used during daily clinical practice to optimise the management of orofacial pain diseases, as well as in conducting future clinical trials for validating new interventions.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  bias; chronic pain; orofacial pain; placebo effect; placebo response; regression to the mean

Mesh:

Year:  2018        PMID: 30326154      PMCID: PMC6331285          DOI: 10.1111/joor.12736

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN: 0305-182X            Impact factor:   3.837


  75 in total

1.  Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos.

Authors:  A J de Craen; J G Tijssen; J de Gans; J Kleijnen
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

2.  The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial.

Authors:  Cory R Herman; Eric L Schiffman; John O Look; D Brad Rindal
Journal:  J Orofac Pain       Date:  2002

Review 3.  Benign migratory glossitis or geographic tongue: an enigmatic oral lesion.

Authors:  Dimitrios Assimakopoulos; George Patrikakos; Christina Fotika; Moses Elisaf
Journal:  Am J Med       Date:  2002-12-15       Impact factor: 4.965

4.  A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study.

Authors:  P Nguyen; S E Mohamed; D Gardiner; T Salinas
Journal:  Cranio       Date:  2001-04       Impact factor: 2.020

5.  Acupuncture and sham acupuncture reduce muscle pain in myofascial pain patients.

Authors:  Greg Goddard; Hiroyuki Karibe; Charles McNeill; Ernesto Villafuerte
Journal:  J Orofac Pain       Date:  2002

6.  Four-year longitudinal course of TMD symptoms in an adult population and the estimation of risk factors in relation to symptoms.

Authors:  M Kamisaka; H Yatani; T Kuboki; Y Matsuka; H Minakuchi
Journal:  J Orofac Pain       Date:  2000

7.  Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area.

Authors:  E Winocur; A Gavish; M Halachmi; I Eli; E Gazit
Journal:  J Orofac Pain       Date:  2000

8.  A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain.

Authors:  E Singer; R Dionne
Journal:  J Orofac Pain       Date:  1997

9.  Longitudinal outcome of temporomandibular disorders: a 5-year epidemiologic study of muscle disorders defined by research diagnostic criteria for temporomandibular disorders.

Authors:  Peter Rammelsberg; Linda LeResche; Samuel Dworkin; Lloyd Mancl
Journal:  J Orofac Pain       Date:  2003

10.  Regression to the mean in treated versus untreated chronic pain.

Authors:  C W Whitney; M Von Korff
Journal:  Pain       Date:  1992-09       Impact factor: 6.961

View more
  2 in total

Review 1.  Evolution of endodontic medicine: a critical narrative review of the interrelationship between endodontics and systemic pathological conditions.

Authors:  Luciano Tavares Angelo Cintra; Maximiliano Schünke Gomes; Cristiane Cantiga da Silva; Flávio Duarte Faria; Francine Benetti; Leopoldo Cosme-Silva; Renata Oliveira Samuel; Tiago Novaes Pinheiro; Carlos Estrela; Alvaro Cruz González; Juan José Segura-Egea
Journal:  Odontology       Date:  2021-07-08       Impact factor: 2.634

2.  Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats.

Authors:  Marek Zubrzycki; Maria Zubrzycka; Grzegorz Wysiadecki; Janusz Szemraj; Hanna Jerczynska; Mariusz Stasiolek
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.